Jiuzhitang Maker has been selected as one of the Top 10 Key Enterprises by the Development and Reform Commission of Daxing District and the management committee of the Biomedicine Industry Park. As one of the 10 key projects of Daxing District, the company’s construction of a scalable stem cell manufacturing platform was referred to be nominated as Beijing’s key project with advanced, precise and sophisticated technologies. Jiuzhitang Maker has been recognized as “ZGC High-Tech Enterprise”, “National High-Tech Enterprise”, “ZGC Gold Seed Enterprise” and “Science-Oriented Small/Medium Business Selected by Ministry of Science and Technology”.
Stemedica Cell Technologies, Inc. is the first US company with approval to treat Alzheimer’s using stem cells, and a clinical grade stem cell manufacturer holding a Drug Manufacturing License issued by the government of California, USA.
Drug Manufacturing License